COVID-19 Vaccine Considerations during Pregnancy and Lactation

Am J Perinatol. 2021 May;38(6):523-528. doi: 10.1055/s-0041-1726390. Epub 2021 May 1.

Authors

Dean Blumberg¹, Aparna Sridhar², Satyan Lakshminrusimha¹, Rosemary D Higgins³, George Saade⁴

Affiliations

¹ Department of Pediatrics, UC Davis Children's Hospital, Sacramento, California.
² Department of Obstetrics and Gynecology, UCLA Health, Los Angeles, California.
³ Department of Global and Community Health, College of Health and Human Sciences, George Mason University, Fairfax, Virginia.
⁴ Department of Obstetrics and Gynecology, University of Texas Medical Branch, Galveston, Texas.

PMID: 33932943
DOI: 10.1055/s-0041-1726390

No abstract available

Publication types

Editorial

MeSH terms

Breast Feeding
COVID-19 Vaccines* / classification
COVID-19 Vaccines* / pharmacology
COVID-19* / epidemiology
COVID-19* / immunology
COVID-19* / prevention & control
Clinical Trials as Topic
Drug Approval / methods*
Female
Humans
Lactation* / drug effects
Lactation* / immunology
Milk, Human* / chemistry
Milk, Human* / immunology
Patient Selection
Pregnancy
Risk Assessment
SARS-CoV-2 / immunology

Substances

COVID-19 Vaccines